Clinical Trial Update: A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE) [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study completed evaluating MK-8527 with a combined oral contraceptive (levonorgestrel/ethinyl estradiol) in the HIV prevention set…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Levonorgestrel/ethinyl estradiol (Levonorgestrel/ethinyl estradiol)
• MK-8527

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis | Phase 1 | Status: COMPLETED